Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Latest on ARS

There is a positive aspect to this fiasco. At least the funds are still available and were NOT swept up into additional dividends. With the stock price still clinging to 3-year lows, maybe additional shares could be purchased for the treasury.

Share
New Message
Please login to post a reply